UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

The Kinase Inhibitor Sorafenib Induces Cell Death through a Process Involving Induction of Endoplasmic Reticulum Stress

Molecular and Cellular Biology, 2007-08, Vol.27 (15), p.5499-5513

2007

Volltextzugriff (PDF)

The Multikinase Inhibitor Sorafenib Induces Apoptosis in Highly Imatinib Mesylate-Resistant Bcr/Abl+ Human Leukemia Cells in Association with Signal Transducer and Activator of Transcription 5 Inhibition and Myeloid Cell Leukemia-1 Down-Regulation

Molecular pharmacology, 2007-09, Vol.72 (3), p.788-795

2007

Volltextzugriff (PDF)

Dinaciclib (SCH727965) inhibits the unfolded protein response through a CDK1- and 5-dependent mechanism

Molecular cancer therapeutics, 2014-03, Vol.13 (3), p.662-674

2014

Volltextzugriff (PDF)

A unified activity-based framework for one-way car-sharing services in multi-modal transportation networks

Transportation research. Part E, Logistics and transportation review, 2022-01, Vol.157, p.102551, Article 102551

2022

Volltextzugriff (PDF)

Enhancing Covid-19 virus spread modeling using an activity travel model

Transportation research. Part A, Policy and practice, 2022-07, Vol.161, p.186-199

2022

Volltextzugriff (PDF)

Corrigendum to “Adaphostin and bortezomib induce oxidative injury and apoptosis in imatinib mesylate-resistant hematopoietic cells expressing mutant forms of Bcr/Abl” [Leuk. Res. 30 (2006) 1263–1272]

Leukemia research, 2019-07, Vol.82, p.46-47

2019

Volltextzugriff (PDF)

MEK1/2 inhibitors sensitize Bcr/Abl+ human leukemia cells to the dual Abl/Src inhibitor BMS-354/825

Blood, 2007-05, Vol.109 (9), p.4006-4015

2007

Volltextzugriff (PDF)

Synergistic Interactions between DMAG and Mitogen-Activated Protein Kinase Kinase 1/2 Inhibitors in Bcr/abl+ Leukemia Cells Sensitive and Resistant to Imatinib Mesylate

Clinical cancer research, 2006-04, Vol.12 (7), p.2239-2247

2006

Volltextzugriff (PDF)

Vorinostat synergistically potentiates MK-0457 lethality in chronic myelogenous leukemia cells sensitive and resistant to imatinib mesylate

Blood, 2008-08, Vol.112 (3), p.793-804

2008

Volltextzugriff (PDF)

Inhibition of MEK/ERK1/2 sensitizes lymphoma cells to sorafenib-induced apoptosis

Leukemia research, 2010-03, Vol.34 (3), p.379-386

2010

Volltextzugriff (PDF)

Adaphostin and bortezomib induce oxidative injury and apoptosis in imatinib mesylate-resistant hematopoietic cells expressing mutant forms of Bcr/Abl

Leukemia research, 2006-10, Vol.30 (10), p.1263-1272

2006

Volltextzugriff (PDF)

Abstract 2686: The CDK inhibitor dinaciclib (SCH727965) inhibits the unfolded protein response (UPR) through a CDK1- and CDK5-dependent mechanism

Cancer research (Chicago, Ill.), 2014-10, Vol.74 (19_Supplement), p.2686-2686

2014

Volltextzugriff (PDF)

Abstract 5412: Synergistic interactions between histone deacetylase inhibitors and aurora kinase inhibitor KW2449 Ph+ cells

Cancer research (Chicago, Ill.), 2010-04, Vol.70 (8_Supplement), p.5412-5412

2010

Volltextzugriff (PDF)

Abstract 2572: The histone deacetylase inhibitors (HDACIs) vorinostat and entinostat interact synergistically with the Bcr/Abl, FLT3, and aurora kinase inhibitor KW-2449 to induce apoptosis in imatininb mesylate (IM)-sensitive and -resistant CML and ALL cells in vitro and in vivo

Cancer research (Chicago, Ill.), 2011-04, Vol.71 (8_Supplement), p.2572-2572

2011

Volltextzugriff (PDF)

Vorinostat Synergistically Potentiates MK-0457 Lethality in Chronic Myelogenous Leukemia (CML) Cells Sensitive and Resistant to Imatinib Mesylate

Blood, 2007-11, Vol.110 (11), p.1041-1041

2007

Volltextzugriff (PDF)

Synergistic Interactions between DMAG and Mitogen-Activated Protein Kinase Kinase 1/2 Inhibitors in Bcr/abl super(+) Leukemia Cells Sensitive and Resistant to Imatinib Mesylate

Clinical cancer research, 2006-04, Vol.12 (7), p.2239-2247

2006

Volltextzugriff (PDF)

Synergistic interactions between dmag and mitogen-activated protein kinase kinase 1/2 inhibitors in Bcr/abi+ leukemia cells sensitive and resistant to imatinib mesylate

Clinical cancer research, 2006, Vol.12 (7), p.2239-2247

2006

Volltextzugriff (PDF)

Studying the Impact of Public Transport on Disaster Evacuation

2020 IEEE 23rd International Conference on Intelligent Transportation Systems (ITSC), 2020, p.1-6

2020

Volltextzugriff (PDF)

Adsorption mechanism of hexavalent chromium onto layered double hydroxides-based adsorbents: A systematic in-depth review

Journal of hazardous materials, 2019-07, Vol.373, p.258-270

2019

Volltextzugriff (PDF)

Dexamethasone for the Treatment of Tuberculous Meningitis in Adolescents and Adults

The New England journal of medicine, 2004-10, Vol.351 (17), p.1741-1751

2004

Volltextzugriff (PDF)

Genome-wide association study identifies susceptibility loci for dengue shock syndrome at MICB and PLCE1

Nature genetics, 2011-11, Vol.43 (11), p.1139-1141

2011

Volltextzugriff (PDF)

Effects of antibacterial ZnO nanoparticles on the performance of a chitosan/gum arabic edible coating for post-harvest banana preservation

Progress in organic coatings, 2021-02, Vol.151, p.106057, Article 106057

2021

Volltextzugriff (PDF)

CuO-Doped Catalyst Synthesized from Red Mud and Rice Husk Ash Using Urea-Nitrate Combustion Technique for p-Xylene Deep Oxidation

Materials transactions, 2019-11, Vol.60 (11), p.2470-2474

2019

Volltextzugriff (PDF)

Recent progress in the preparation, properties and applications of superhydrophobic nano-based coatings and surfaces: A review

Progress in organic coatings, 2019-07, Vol.132, p.235-256

2019

Volltextzugriff (PDF)

Safety and immunogenicity of Nanocovax, a SARS-CoV-2 recombinant spike protein vaccine: Interim results of a double-blind, randomised controlled phase 1 and 2 trial

The Lancet regional health. Western Pacific, 2022-07, Vol.24, p.100474-100474, Article 100474

2022

Volltextzugriff (PDF)

1 – 25 von 226

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(188)
Mit Volltextzugriff
(185)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(3)
... seit 90 Tagen
(5)

Menü

Weitere Dienste

Einstellungen

The Kinase Inhibitor Sorafenib Induces Cell Death through a Process Involving Induction of Endoplasmic Reticulum Stress

The Multikinase Inhibitor Sorafenib Induces Apoptosis in Highly Imatinib Mesylate-Resistant Bcr/Abl+ Human Leukemia Cells in Association with Signal Transducer and Activator of Transcription 5 Inhibition and Myeloid Cell Leukemia-1 Down-Regulation

Dinaciclib (SCH727965) inhibits the unfolded protein response through a CDK1- and 5-dependent mechanism

A unified activity-based framework for one-way car-sharing services in multi-modal transportation networks

Enhancing Covid-19 virus spread modeling using an activity travel model

Corrigendum to “Adaphostin and bortezomib induce oxidative injury and apoptosis in imatinib mesylate-resistant hematopoietic cells expressing mutant forms of Bcr/Abl” [Leuk. Res. 30 (2006) 1263–1272]

MEK1/2 inhibitors sensitize Bcr/Abl+ human leukemia cells to the dual Abl/Src inhibitor BMS-354/825

Synergistic Interactions between DMAG and Mitogen-Activated Protein Kinase Kinase 1/2 Inhibitors in Bcr/abl+ Leukemia Cells Sensitive and Resistant to Imatinib Mesylate

Vorinostat synergistically potentiates MK-0457 lethality in chronic myelogenous leukemia cells sensitive and resistant to imatinib mesylate

Inhibition of MEK/ERK1/2 sensitizes lymphoma cells to sorafenib-induced apoptosis

Adaphostin and bortezomib induce oxidative injury and apoptosis in imatinib mesylate-resistant hematopoietic cells expressing mutant forms of Bcr/Abl

Abstract 2686: The CDK inhibitor dinaciclib (SCH727965) inhibits the unfolded protein response (UPR) through a CDK1- and CDK5-dependent mechanism

Abstract 5412: Synergistic interactions between histone deacetylase inhibitors and aurora kinase inhibitor KW2449 Ph+ cells

Abstract 2572: The histone deacetylase inhibitors (HDACIs) vorinostat and entinostat interact synergistically with the Bcr/Abl, FLT3, and aurora kinase inhibitor KW-2449 to induce apoptosis in imatininb mesylate (IM)-sensitive and -resistant CML and ALL cells in vitro and in vivo

Vorinostat Synergistically Potentiates MK-0457 Lethality in Chronic Myelogenous Leukemia (CML) Cells Sensitive and Resistant to Imatinib Mesylate

Synergistic Interactions between DMAG and Mitogen-Activated Protein Kinase Kinase 1/2 Inhibitors in Bcr/abl super(+) Leukemia Cells Sensitive and Resistant to Imatinib Mesylate

Synergistic interactions between dmag and mitogen-activated protein kinase kinase 1/2 inhibitors in Bcr/abi+ leukemia cells sensitive and resistant to imatinib mesylate

Studying the Impact of Public Transport on Disaster Evacuation

Adsorption mechanism of hexavalent chromium onto layered double hydroxides-based adsorbents: A systematic in-depth review

Dexamethasone for the Treatment of Tuberculous Meningitis in Adolescents and Adults

Genome-wide association study identifies susceptibility loci for dengue shock syndrome at MICB and PLCE1

Effects of antibacterial ZnO nanoparticles on the performance of a chitosan/gum arabic edible coating for post-harvest banana preservation

CuO-Doped Catalyst Synthesized from Red Mud and Rice Husk Ash Using Urea-Nitrate Combustion Technique for p-Xylene Deep Oxidation

Recent progress in the preparation, properties and applications of superhydrophobic nano-based coatings and surfaces: A review

Safety and immunogenicity of Nanocovax, a SARS-CoV-2 recombinant spike protein vaccine: Interim results of a double-blind, randomised controlled phase 1 and 2 trial

Suchergebnisse filtern